Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine 0.01% for NITM in Children
NCT06697522Phase 3Completed
- Sponsor
- Ocumension Biotech
- Start
- Jun 2023
- Primary completion
- Oct 2023
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in Transient Myopia, sponsored by Ocumension Biotech. Started Jun 2023; status: completed.
02
Drugs
atropine
03
Conditions
Transient Myopia
Beyond the preview
Go deeper on NCT06697522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06697522.